An Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Chronic Urticaria (MK-4117-201)
Status:
Completed
Trial end date:
2014-03-13
Target enrollment:
Participant gender:
Summary
This is a study to evaluate the efficacy and safety of desloratadine (MK-4117) in Japanese
participants with chronic urticaria. The primary hypothesis is that the efficacy of
desloratadine 10 mg and 5 mg is superior to placebo as based on the change from Baseline in
the sum score of pruritus/itch and rash as assessed by the Investigator at Week 2.